Download Program
Download Abstract Book
The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
Topics
Meeting category
Date(s)
19 Sep 2024 - 21 Sep 2024
Program Language
English, French
Location
Cairo,
Egypt
Meeting type
Hybrid Meeting
CME Credits
14
Society on Liver Disease in Africa
Conference on Liver Disease in Africa (COLDA) 2024
Related Enduring Materials
Enduring Materials
Thursday, 19 September
Opening of the Conference -
Life Time Achievement of John C Martin
WHO Global Hepatitis Report 2024: Where do we stand in Africa?
Implementing the New WHO Guidelines for Hepatitis B Care: Challenges and Opportunities
Community Perspective on New Guidelines and Their Implementation
Session 1: Basic Virology -
Harry Janssen, MD, PhD
Introduction of the ICE-HBV Working Group
Definition of Functional Cure - New Monitoring Tools
Erasmus MC, University Hospital Rotterdam, the Netherlands / Toronto Centre for Liver Disease, Canada
Session 2: Diagnostics of Viral Hepatitis -
Point of Care Testing - Viral Hepatitis
Barriers & Access to Commodities : Access to Accurate and Affordable Diagnostics Are Main Barrier to Linkage to Care
Mini- Oral Abstract Presentations -
The Impact of Integration and Decentralization of HBV Services on Enhancing HBV Care Continuum: An Interrupted Time Series
#8 - Jean Damascene Makuza
Canada
Session 3: Viral Hepatitis in Pregnancy -
Viral Hepatitis During Pregnancy
(Triple) Elimination of Vertical Transmission / Path to Elimination for HIV
Friday, 20 September
Session 4: Liver Transplantation -
Eduard Jonas, MB, ChB, MMed, FCS, PhD
Nabil Debzi, MD
Liver Transplantation - Cote d'Ivoire
Liver Transplantation - South Africa
University of Cape Town / Groote Schuur Hospital, South Africa
Liver Transplantation - Algeria
Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers, Algeria
Session 5: Forum for Collaborative Research - Implementation of HBV Clinical Research in Africa -
Veronica Miller, PhD
Towards Accelerating HBV Clinical Research in Africa
Forum for Collaborative Research, UC Berkeley School of Public Health, United States
Session 6: Liver Disease & Comorbidities -
The Role of Noncommunicable Diseases (NCDs) and Liver Disease
Role of Neglected Tropical Diseases in Liver Disease / Schistosomiasis
Session 7: AILD Clinical Research in Africa (AASLD) -
Diagnosis and Management of Autoimmune Hepatitis
Clinical Presentation and Management of Primary Sclerosing Cholangitis
Autoimmune Hepatitis in Pediatric Patient Population
Understanding the Natural History of Autoimmune Liver Diseases in Under-represented African Patient Population
Session 8: HCC Clinical Cases -
Introduction: Prevalence of HCC in Africa - Rapid Changes / New HCC Guidelines
Early Detection of Liver Cancer / Biomarkers
Healthy Livers Healthy Lives -
Jeffrey V. Lazarus, PhD, MIH, MA
17:50 EEST
Healthy Livers Healthy Lives - Key Lecture
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Saturday, 21 September
Session 9: EASL - Advancements in Hepatology - Navigating SLD and ACLF -
New SLD Nomenclature
Acute on Chronic Liver Failure (ACLF)
Session 11: Elimination of Viral Hepatitis - Governmental Endorsement -
Abdulaziz Mohammed, MBBS, MHPM, MPH-FE, FWACP
Perspective of Africa CDC
Africa Centres for Disease Control and Prevention, Ethiopia
Perspective of WHO African Region (AFRO)
Role of the MoH in Scaling Up and Achieving the Goals
General
Welcome
The Conference on Liver Disease in Africa (COLDA) 2024 took place from 19-21 September as a hybrid meeting in Cairo, Egypt.
Co-organized by SOLDA and Academic Medical Education in close collaboration with regional societies, COLDA 2024 aims at empowering healthcare professionals (HCPs) to diagnose, prevent, treat, and achieve a cure for liver diseases for the benefit of patients in Africa.
This being the 7th COLDA, we continue to cultivate a platform that provides a unique opportunity for clinicians, researchers, policymakers, industry representatives, and other healthcare professionals in the African region. Together with support from an international community of experts, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context.
We aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches, state-of-the-art lectures, oral and poster abstract presentations, roundtable discussions, and debates with ample time for discussion.
We are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge, and experience a wide spectrum of topics related to liver disease.
Program Chairs 2024
Local Chairs 2024
General Information
Who Should Attend?
• Physicians
• Hepatologists
• Gastroenterologists
• Researchers
• Other healthcare professionals (nurses, clinical officers, community health workers, among others)
• Hepatologists
• Gastroenterologists
• Researchers
• Other healthcare professionals (nurses, clinical officers, community health workers, among others)
Meeting Objectives
COLDA aims to:
- Gather experts from the African region involved in the research, diagnosis, and treatment of liver diseases in an interactive conference setting;
- Discuss the diagnostic, therapeutic, and preventative efforts of liver disease tailored to regional and local needs, translating best practices into daily practice guidelines and policies;
- Contribute towards hepatitis elimination efforts;
- Leverage on the findings from international studies through the delivery of updates from major meetings that can be applied at the local and regional level to combat liver diseases;
- Facilitate a robust dialogue among participants through interactive networking and a networking reception; and
- Foster new and lasting interdisciplinary partnerships and collaborations among various researchers to improve knowledge sharing with aim of combating liver diseases in Africa.
- Gather experts from the African region involved in the research, diagnosis, and treatment of liver diseases in an interactive conference setting;
- Discuss the diagnostic, therapeutic, and preventative efforts of liver disease tailored to regional and local needs, translating best practices into daily practice guidelines and policies;
- Contribute towards hepatitis elimination efforts;
- Leverage on the findings from international studies through the delivery of updates from major meetings that can be applied at the local and regional level to combat liver diseases;
- Facilitate a robust dialogue among participants through interactive networking and a networking reception; and
- Foster new and lasting interdisciplinary partnerships and collaborations among various researchers to improve knowledge sharing with aim of combating liver diseases in Africa.
Learning Objectives
After participating in COLDA, participants will be able to:
- Discuss the epidemiology and treatment of liver disease at an individual and population level;
- Ensure the knowledge and availability of HBV and HCV therapy and their correct usage;
- Discuss evolving modalities of monitoring liver disease and their availability in the African setting; and
- Update on new developments in the investigation of liver disease and their use in an African setting.
- Discuss the epidemiology and treatment of liver disease at an individual and population level;
- Ensure the knowledge and availability of HBV and HCV therapy and their correct usage;
- Discuss evolving modalities of monitoring liver disease and their availability in the African setting; and
- Update on new developments in the investigation of liver disease and their use in an African setting.
Practical Information
Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the conference is English
Enduring Materials
Conference materials can be obtained upon registration at the registration desk at the Conference Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Program Coordinator
Scientific Committee
To augment the organizing committee, the following are scientific committee members
-
Mary Afihene, MBChB, FWACP – Kwame Nkrumah University / Komfo Anokye Teaching Hospital, Ghana
-
Kosh Agarwal, MD - King’s College Hospital, United Kingdom
-
Bisi Bright, BPharm(Hons), MPH, FPCPharm, FPSN, C.Psych - LiveWell Initiative (LWI), Nigeria
-
Maria Buti, MD, PhD - Hospital General Universitari Valle Hebron, Spain
-
Alice Guingané, MD, PhD - Bogodogo University Hospital Center / University of Montpellier, Burkina Faso / France
-
Jessica Hicks - The World Hepatitis Alliance, United Kingdom
-
Kenneth Kabagambe - National Organization for People Living with Hepatitis B, Uganda
-
Olufunmilayo Lesi, MD, MBA, FWACP, FMCP - World Health Organization, Switzerland
-
Casimir Manzengo, MD, MPH - World Health Organization, Gabon
-
Emmanuel Musabeyezu, MD, FCP(SA) - King Faisal Hospital, Rwanda
-
Yvonne Nartey, MBChB, MSc, MPhil - Cape Coast Teaching Hospital, Ghana
-
John Rwegasha, MBChB, MMed, FRCP(Lond), MSc - Muhimbili National Hospital, Tanzania
-
Edford Sinkala, MD, PhD - University Teaching Hospital / University of Zambia, Zambia
-
Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland
-
Mark Sonderup, BPharm, MBChB, FCP(SA), MMed - University of Cape Town, South Africa
-
Elijah Songok, MD, PhD - Kenya Medical Research Institute, Kenya
-
Christian Tzeuton, MD - Douala Medical School / Société Camerounaise de Gastro-Enterologie, Cameroon
-
Lewis Roberts, MBChB, PhD - Mayo Clinic, USA
-
Geoffrey Dusheiko, MBBS, FCP(SA), FRCS - King's College Hospital / University College London Medical School, United Kingdom
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Support
Silver Level
Bronze Level
Principal Supporter
Supporter
Stephan Urban Foundation Scholarship
Stephan Urban Foundation
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in liver diseases in Africa.
This collaboration plays a vital role in both the organizational as well as the scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Magda Sevlidou at magda.sevlidou@amededu.com or call +31 30 230 7147.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, program book, the streaming platform, and our website
- Digital advertising opportunities
- Social media shout-outs
- Logo on the digital conference bag
- Exhibition
*Subject to the support level
Endorsers
Media Partners
Endorsers
Burkinabé Society of Hepatogastroenterology (SO.BU.H.GE.ED)
NOPLHB - National Organization for People Living with Hepatitis B
Partners
A 25% discount on the meeting registration fee is offered to the members/employees of our endorsers. Please reach out to your organization for your discount code.
If you would like your organization to endorse COLDA 2024, please contact Hana Augustine at magda.sevlidou@amededu.com.
Previous Editions
Top-Rated Materials from Previous Edition
The Story of Hepatitis C: Translating Science to Clinical Reality - Harvey J. Alter, MD, MACP
COLDA 2021
Accreditation
Accreditation Statement
The Conference on Liver Disease in Africa (COLDA) 2024, Cairo, Egypt 19/09/2024 - 21/09/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 14.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Language
Related Programs
